IACIX | VMVAX | IACIX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 13 years | - |
Gain YTD | 5.116 | 12.571 | 41% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 300M | 32.8B | 1% |
Annual Yield % from dividends | 2.07 | 2.14 | 97% |
Returns for 1 year | 4.56 | 12.17 | 37% |
Returns for 3 years | -20.39 | 9.56 | -213% |
Returns for 5 years | 4.77 | 38.28 | 12% |
Returns for 10 years | -7.15 | 83.63 | -9% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FDCGX | 85.82 | -0.30 | -0.35% |
Fidelity Advisor Consumer Staples C | |||
IUAIX | 42.31 | -0.20 | -0.47% |
VY® Invesco Equity and Income I | |||
EMWLX | 15.70 | -0.09 | -0.57% |
Lord Abbett Emerging Markets Equity R6 | |||
PXGOX | 16.53 | -0.10 | -0.60% |
Impax Global Opportunities Institutional | |||
JNGLX | 68.66 | -0.48 | -0.69% |
Janus Henderson Global Life Sciences D |